NEUCHATEL, Switzerland-- (BUSINESS WIRE)-- Masimo (NASDAQ: MASI) announced today the CE marking of the Rad-97 ™ Pulse CO-Oximeter ®. Rad-97 offers the same Measure-through Motion and Low Perfusion™ ...
Masimo Corporation ( MASI) recently announced that Mercy Hospital of Buffalo - one of the largest hospitals in Western New York - expanded continuous patient monitoring using Masimo SET pulse oximetry ...
Masimo announced US FDA 510(k) clearance and CE Mark of its new Radical-7 with rainbow acoustic monitoring capability for continuous display of the acoustic respiration rate (RRa) waveform and ...
Masimo Corporation MASI recently announced the publication of the results of a prospective study in the Sri Lanka Journal of Child Health, demonstrating the efficacy of using Masimo Signal Extraction ...
NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today the CE marking of Eve™, a critical congenital heart disease (CCHD) newborn screening application, for the Rad-97™ Pulse ...
Agreement with Leading Supplier Advances National Push into the Animal Healthcare Market. IRVINE, Calif., June 11, 2013 /PRNewswire/ -- Masimo (MASI) announced today that Butler Schein Animal Health, ...
Masimo today announced the results of a prospective study published in the International Journal of Neonatal Screening in which researchers in Marrakesh, Morocco, conducted the first Moroccan study on ...